Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BioStock: Positive results for RhoVac in 3-year follow-up of phase I/II-study

The results speak for themselves when RhoVac presents its follow-up of the phase I/II study conducted three years ago at Rigshospitalet in Copenhagen. No metastases, no indication of a need for further treatment in order to maintain immunity, and no indication of significant development of PSA in treated patients. This is great news for the company, says CEO Anders Månsson when BioStock contacts him.Read the full article at biostock.se:https://www.biostock.se/en/2021/10/positive-results-for-rhovac-in-3-year-follow-up-of-phase-i-ii-study/This is a press release from BioStock - Connecting

BioStock: Ultimovacs enters next step in new vaccine platform development

Ultimovacs’ TENDU trial is a clinical phase I study aimed at testing the company’s TET platform for cancer vaccine development in prostate cancer patients. The study was initiated earlier this year with the first cohort of patients; now the company has announced dosing the first patient in the second of three cohorts for the TENDU study.Read the full article at biostock.se:https://www.biostock.se/en/2021/10/ultimovacs-enters-next-step-in-new-vaccine-platform-development-2/This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

BioStock: Ultimovacs enters next step in new vaccine platform development

Ultimovacs’ TENDU trial is a clinical phase I study aimed at testing the company’s TET platform for cancer vaccine development in prostate cancer patients. The study was initiated earlier this year with the first cohort of patients; now the company has announced dosing the first patient in the second of three cohorts for the TENDU study.Read the full article at biostock.se: https://www.biostock.se/en/2021/10/ultimovacs-enters-next-step-in-new-vaccine-platform-development-2/ This is a press release from BioStock - Connecting Innovation & Capital.

Genovis AB (publ.) hires new CFO

Genovis has hired Magnus Långberg as the new CFO of the Group; he will begin in January 2022.Magnus Långberg has over 20 years of experience from a variety of positions within finance and management at international life science companies. He will be joining Genovis from his most recent position at Hemocue AB. Before that he worked at companies such as QPharma and BD Medical. “I’m pleased to be able to welcome Magnus Långberg as the new CFO of Genovis. Magnus will have an important role in Genovis’ continued development and I look forward to working with him,” says Fredrik Olsson, CEO of

Evolution and Betway strengthen partnership in the US

Evolution has announced that it has signed an agreement with Super Group owned Betway for the provision of Evolution’s online Live Casino and ‘First Person’ RNG-based casino games in the US states of New Jersey and Pennsylvania.Betway is a globally recognised online betting and gaming brand and is a long-standing Evolution customer. Betway has entered the US market through an exclusive brand licensing agreement with Digital Gaming Corporation (DGC). The Evolution-Betway deal will see Evolution online Live Casino games and ‘First Person’ RNG-casino games made available to Betway players

Evolution´s Nomination Committee for the 2022 Annual General Meeting

In accordance with the resolution of the Annual General Meeting, the three largest shareholders in the company as per the last business day of August who wish to appoint a representative shall appoint the Nomination Committee. If any of these shareholders chooses to waive their right to elect a representative, their right is transferred to the shareholder who, after these shareholders, has the largest share ownership and wishes to use this right. In addition, a member of the Board of Directors who is independent in relation to the company’s management shall be a member of the Nomination

Nobina to expand in Norrbotten under new contract

Under a new contract commencing in June 2022, Nobina has been awarded an expanded assignment by Länstrafiken i Norrbotten to operate and develop services on the main route between Boden and Luleå. The contract, which will be Nobina’s fourth in Region Norrbotten and third in collaboration with Länstrafiken i Norrbotten, is valued at approximately SEK 50 million over a contract period of two years. No additional optional years are included.The new contract entails that Nobina will continue to expand its operations in Norrbotten, which currently comprise services in, for example, Piteå,

Skanska invests NOK 210M, about SEK 210M in a residential development property in Bærum, Norway

Skanska has acquired a development property in Bærum, Norway.  The net investment for residential purpose amounts to NOK 210M, about SEK 210M. The seller is Profier.The property Kirkeveien 59 is ready zoned for block housing and concentrated single-family housing. Skanska plans to build 50 apartments and 28 terraced houses. The project will be BREEAM-certified and construction work is expected to start 2023. Skanska is one of the leading construction- and project development companies in the Nordics, with operations in building construction and civil engineering in Sweden, Norway and

Mandatory notification of trade

Anooj Unarket, Board member of Otello Corporation ASA, has on behalf of certain related parties, as of 5th October 2021, acquired interests in shares of Otello Corporation ASA. The balance of Anooj Unarket and related parties’ holdings after the transaction totals 25,914,214 shares. Please refer to the attached notification of trading for further details. This information is subject to disclosure requirements in regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.

Transactions in connection with share buy-back programme

On 4 March 2021, H+H International A/S (hereinafter referred to as “H+H” or “the Company”) initiated a share buy-back programme in compliance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on Market Abuse and Commission Delegated Regulation (EU) 1052/2016 of 8 March 2016 (the “Safe Harbour Regulation”). On 18 March 2021, the share buy-back programme was increased by DKK 15 million, thereby increasing the maximum aggregate purchase price of the shares to be bought back under the programme to DKK 115 million. The share buy-back

Fabege acquires SHH Bostad AB

SHH is a real estate development company with a focus on residential and local authority properties. Fabege’s strategy of optimising the value of its residential development rights portfolio is thereby being reinforced by the company acquiring both expertise and more development rights in its home market of Stockholm. All the shares in SHH are being acquired for a purchase price of SEK 880m. As of 18 October, SHH will be a wholly owned subsidiary of Fabege.SHH was founded in 2010 and has since completed over 40 real estate projects, with approximately 2,100 homes. At mid-year 2021, SHH had

Ocean Yield ASA: Commencement of offer period for recommended voluntary cash offer for all outstanding shares of Ocean Yield ASA at NOK 41 per share

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, INTO OR WITHIN CANADA, AUSTRALIA, NEW ZEALAND, SOUTH-AFRICA, HONG KONG, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL Oslo, 6 October 2021 – Reference is made to the announcement on 13 September 2021 regarding an offer to acquire all outstanding shares of Ocean Yield ASA ("Ocean Yield" or the "Company") and the Oslo Stock Exchange's announcement of approval of the offer document dated 5 October 2021 (the "Offer Document"). Octopus Bidco AS (the "Offeror"), a

AlzeCure Pharma develops novel analgesic drug based on Nobel prize-winning discoveries

Stockholm, Sweden, October 6, 2021. AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of candidate drugs for diseases affecting the central nervous system, with projects in both Alzheimer’s disease and pain, today announced that the its novel clinical candidate drug ACD440 for peripheral neuropathic pain, is based on the seminal discoveries of TRPV1 by Prof. Julius, and for which he was awarded the Nobel Prize in Medicine 2021.David Julius, PhD, professor and chair of the Department of Physiology and Morris Herzstein Chair in Molecular

First day of trading in Storskogen’s B-shares on Nasdaq Stockholm

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT. Neither this announcement, nor anything contained herein, shall form the basis of, or be relied upon in connection with, any offer or commitment whatsoever in any jurisdiction. Investors should not subscribe for or purchase any securities referred to in this announcement except on the basis of information contained in a prospectus in its final form (the “Prospectus”) that has been

New EU tire labels help drivers – especially useful for online shoppers

Europe has become the first region in the world to start using an ice grip symbol for tires. A snow grip symbol and QR code leading to a massive database have also been added to the tires. The new symbols help consumers to compare different alternatives and to choose safe tires that reduce emissions. As a winter tire pioneer, Nokian Tyres  has long advocated for developing the labels.  Tire labels are being renewed across the entire EU. New labels are required on tires manufactured after May 1, 2021, so the new labels will start gradually appearing on tires

Handelsbanken’s interim report for January –September 2021 will be presented on Wednesday, 20 October

Handelsbanken publishes its interim report for January ­– September 2021 at 6:30 a.m. CET on Wednesday, 20 October. The Group Chief Executive Carina Åkerström will present the Bank’s interim report at 8:30 a.m. CET. at a meeting with the media and analysts, at Handelsbanken’s head office, Kungsträdgårdsgatan 2, Stockholm. The presentation will be held in Swedish, with simultaneous interpretation into English. A link to the presentation will be available at handelsbanken.com/ir. Registration in advance is required, please send your notification of your intention to attend, by email to

Invitation to presentation of Hexagon's Interim Report on 28 October

Hexagon will release its Interim Report for the third quarter 2021 on Thursday 28 October at approximately 08:00 CET. A combined telephone conference and live webcast concerning the report will be presented by President and CEO Ola Rollén on the same day at 10:00 CET. Please call +46 (0) 8 566 426 51 (SWE), +44 (0) 333 300 0804 (UK), +1 631 913 1422 (US) (code: 24159039#) to participate in the telephone conference or visit hexagon.com to access the webcast. The presentation material will also be available for viewing on the Company’s website on-demand. For further information,

Stille to Launch a New General Surgery Table

Stille AB (publ) announces exclusive collaboration with GE Healthcare for a new general surgery table in the United States.The new general surgery table, GS2®, has been developed to address a growing need for a premium general surgery table that satisfies the needs of multi-disciplinary surgery units such as Ambulatory Surgery Centers (ASC), while also providing a cost effective high-value solution. These healthcare facilities perform procedures across a wide spectrum of surgical disciplines alongside the OEC C-arms such as orthopedics, general surgery, cardiovascular, and urology, as well

Q4: Robust organic growth and earnings performance

Fourth quarter •    The acquisition of Centralpoint Holding B.V. (“Centralpoint”) was conducted on June 3, 2021 and, accordingly, has been included in the consolidated income statement and balance sheet from the fourth quarter 20/21. •    Net sales rose 77.6 per cent to SEK 5,105 million (2,874). •    Organic sales growth was 20.5 per cent (neg: 2.3), of which SMB accounted for 17.9 per cent (neg: 2.6), LCP 23.7 per cent (neg: 1.5) and B2C 7.9 per cent (neg: 8.5). •    The gross margin amounted to 14.8 per cent (15.1). •    Adjusted EBITA amounted to SEK 229 million (101),

Invitation to Stora Enso’s Q3 2021 results webcast on 20 October 2021

STORA ENSO OYJ INVESTOR NEWS 6 October 2021 at 9:00 EESTStora Enso will publish its January-September 2021 Interim Report on Wednesday 20 October 2021 approximately at 08:30 EEST (07:30 CEST).Analysts, investors and media are invited to participate in the webcast and conference call at 15:00 EEST (14:00 CEST, 13:00 BST, 08:00 EDT) on the same day. The result will be presented by the President and CEO Annica Bresky, CFO Seppo Parvi, and SVP, Head of Investor Relations Ulla Paajanen, and may be accessed at https://edge.media-server.com/mmc/p/xgicessg. All participants can follow the

Fazer accelerates the growth of gluten-free bakery products in Finland

Fazer acquired the gluten-free Vuohelan bakery in Lahti last year and is constantly developing its gluten-free product family. The company has already brought a dozen gluten-free novelties to the market this year and will continue to invest in the production of gluten-free products. The market for gluten-free fresh bakery products in Finland has grown by 17% within this year [1)].Expanding to the gluten-free market is part of Fazer’s consumer-centric strategy. The integration of the Vuohelan bakery has gone well and it has become a natural part of Fazer’s bakery network. Fazer is the market

Lindab acquires the Swiss ventilation company Tecnovent

Lindab expands its current operations in Switzerland with the acquisition of Tecnovent SA. With the acquisition, Lindab will get access to sales and production of ventilation grilles, roof hoods and rectangular ventilation ducts. Tecnovent has a strong position in the south east part of Switzerland and is currently one of Lindab’s distributors.Tecnovent is established in Lugano in the Italian-speaking part of Switzerland, where Lindab has no operations of its own. They are manufacturers of ventilation products such as roof hoods, grilles, and dampers, which gives Lindab access to local

Wärtsilä report anticipates that accelerated adoption of renewables can reduce electricity production costs by up to 50 percent

Wärtsilä Corporation, Press release, 6 October 2021 at 8:30 AM EESTThe technology group Wärtsilä has issued a report ahead of COP26, the UN’s Climate Change Conference to be held in Glasgow this autumn, demonstrating the environmental and economic opportunities for states that decarbonise rapidly. The report will be presented at the Economist Sustainability Week event today, 6 October. The ‘Front-Loading Net Zero’  report states that electricity production costs could be reduced by up to 50% by 2050 if countries and states adopt 100%

Readly enters into agreement to acquire Toutabo, the owner of ePresse, establishing a leading position in France

Insider information: Readly International AB (publ) (“Readly''), the European category leader within digital magazine subscriptions, has entered into an agreement to acquire 97.3% of the issued shares in Toutabo SA (“Toutabo”, “the Acquisition”), a leading subscription provider in France and owner of the digital subscription provider ePresse, from the founders and the institutional owners (the “Sellers”). The total purchase price amounts to up to approximately EUR 8.2 million on a cash and debt free basis (subject to any post signing adjustments), with an initial consideration of

There are no items matching the current filter
There are no more items matching the current filter
Back to top